04:38 , Aug 1, 2019 |  BC Innovations  |  Distillery Therapeutics

ARID5A as a therapy for obesity

DISEASE CATEGORY: Endocrine/metabolic INDICATION: Obesity Raising activity levels of the transcription factor ARID5A could help treat obesity by inhibiting PPARγ-mediated adipogenesis. ARID5A overexpression decreased adipogenesis and repressed transcription of PPARγ, a master regulator of the...